Document is current
Any future updates will be listed below
-
Authors
Weng, Lihui
Seelig, Davis
Souresrafil, Omid
-
Funding
Funding for this research was provided by:
EmboMedics Inc (00049685 (Weng 2015))
- License Information
-
More Information
Article History
Received: 11 December 2017
Accepted: 6 March 2018
First Online: 14 March 2018
Compliance with Ethical Standards
:
: Lihui Weng received research grants from EmboMedics and also is a shareholder of EmboMedics Inc. Omid Souresrafil is shareholder of EmboMedics Inc. Davis Seelig has no conflict of interest.
